JUVENA THERAPEUTICS INC

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• 08 Jan 2026Regenerative Polypeptides And Uses Thereofapplication
• 31 Jul 2025Heparin-associated Polypeptides And Uses Thereofapplication
• 15 Jul 2025Regenerative Polypeptides and Uses Thereofgranted
• 17 Jun 2025Regenerative Polypeptides And Uses Thereofgranted
• 20 Mar 2025Therapeutic Compositions And Methods Of Use Thereofapplication
• 13 Jun 2024Heparin-Associated Polypeptides and Uses Thereofapplication
• 08 Feb 2024Regenerative Polypeptides And Uses Thereofapplication
• 25 Jan 2024Heparin-Associated Polypeptides and Uses Thereofapplication
• 21 Dec 2023Heparin-Associated Polypeptides and Uses Thereofapplication
• 05 Oct 2023Regenerative Polypeptides and Uses Thereofapplication
• 29 Dec 2022Heparin-Associated Polypeptides and Uses Thereofapplication
• 11 Feb 2021Heparin-Associated Polypeptides and Uses Thereofapplication

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.